562
Participants
Start Date
November 9, 2022
Primary Completion Date
June 13, 2023
Study Completion Date
October 3, 2023
EHR Nudge
Clinicians in Arm 1 (intervention) will receive a EHR notification with option to opt-out for palliative care referral for any eligible high-risk patient, defined by a risk score ≥1 for Stage IV cancer patients and ≥2 for Stage III cancer patients. If the risk score is above 8, they will be scheduled within 2 weeks, and all other patients will be scheduled within 4 weeks. Clinician will have the option to opt-out for any patient by responding to the notification which will be sent to the research coordinator. If the clinician does not respond, the research coordinator will approach patient via telephone, explain the rationale for referral based on a predetermined script, and offer and schedule an outpatient or telemedicine palliative care consultation per patient preference. Follow-up visits will occur at the discretion of the palliative care clinician, usually monthly.
Tennessee Oncology, PLLC, Nashville
Tennessee Oncology
OTHER
Emerson Collective
UNKNOWN
Abramson Cancer Center at Penn Medicine
OTHER